<DOC>
	<DOC>NCT00270517</DOC>
	<brief_summary>This study will compare the efficacy, safety and tolerability of EDP-420 versus another oral antibiotic in the treatment of community acquired pneumonia</brief_summary>
	<brief_title>Comparative Study of EDP-420 Versus Another Antibiotic in the Treatment of Community Acquired Pneumonia</brief_title>
	<detailed_description />
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Telithromycin</mesh_term>
	<criteria>Recent respiratory illness with signs and symptoms and chest Xray consistent with the diagnosis of communityacquired pneumonia. Suitable candidate for oral antibiotic therapy and able to swallow large capsules intact If female, must be nonlactating and at no risk for pregnancy Other infections Other pulmonary diseases requirement multiple antibacterial medications or long duration of therapy History of hypersensitivity, allergic or adverse reactions to macrolide, ketolide, azalide or streptogramins Evidence of uncontrolled clinically significant disease, malignancy, or other abnormality Requirement of parenteral antimicrobial therapy for treatment of pneumonia Currently receiving or likely to receive any known inhibitors or inducers of cytochrome P450 mediated drug metabolism Immunocompromised subjects</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2006</verification_date>
</DOC>